By Martin Burns
Sufferers of age-related macular degeneration (AMD) can now be treated at a new clinic in Reading.
The specialist centre is based at the Royal Berkshire Hospital and offers a drug called Lucentis to patients with wet AMD.
In addition, reports the Reading Post, a new system has been developed by the Royal Berkshire NHS Foundation Trust to speed up the process of referral.
The trust took action in 2007 after people with the condition had been subject to a postcode lottery, with many having to pay £1,000 for the injections.
Around 275 patients are treated at the clinic and it is hoped that people who are referred to it will be contacted within 48 hours and able to start receiving their Lucentis injections within a fortnight.
Injections are administered every month to sufferers.
The active ingredient in Lucentis is ranibizumab.
It works by inhibiting vascular endothelial growth factor A, which causes abnormal growth of blood vessels in wet AMD sufferers.
by Adrian Galbreth